Peter Stein

Peter Stein, M.D., is the Deputy Director, Office of New Drugs, in FDA’s Center for Drug Evaluation and Research

Tue, 01/02/2018 - 12:01
FDA, International Regulators Look at Common Challenges to InnovationMore than 500 experts convene at summit in Kyoto, Japan
Tue, 01/02/2018 - 12:01
Regulatory experts from around the world, including the Food and Drug Administration (FDA), gathered recently to discuss issues such as regenerative medical products, international collaboration to fight antimicrobial resistance (AMR), and…